Literature DB >> 4716545

Lack of specific inhibition of Vaccinia plaque formation by bacteriophage lambda products.

A Brown, S N Cohen.   

Abstract

Unsuccessful efforts to confirm the production of a specific antiviral agent (phagicin) by bacteriophage lambda are reported.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4716545      PMCID: PMC422775          DOI: 10.1128/iai.7.6.862-864.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Nutrition of animal cells in tissue culture; initial studies on a synthetic medium.

Authors:  J F MORGAN; H J MORTON; R C PARKER
Journal:  Proc Soc Exp Biol Med       Date:  1950-01

3.  Nonchromosomal antibiotic resistance in bacteria. V. Isolation and characterization of R factor mutants exhibiting temperature-sensitive repression of fertility.

Authors:  R P Silver; S N Cohen
Journal:  J Bacteriol       Date:  1972-06       Impact factor: 3.490

4.  Inhibition of growth of uninfected and rous sarcoma virus-infected chick-embryo fibroblasts by rifampicin.

Authors:  H L Robinson; W S Robinson
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

5.  Genetic expression in bacteriophage lambda. 3. Inhibition of Escherichia coli nucleic acid and protein synthesis during lambda development.

Authors:  S N Cohen; A C Chang
Journal:  J Mol Biol       Date:  1970-05-14       Impact factor: 5.469

6.  Differential inhibition by phagicin of DNA synthesis in cells infected with vaccinia.

Authors:  E S Meek; M Takahashi
Journal:  Nature       Date:  1968-11-23       Impact factor: 49.962

7.  The inhibition of vaccinia virus multiplication by isatin-beta-thiosemicarbazone.

Authors:  B Woodson; W K Joklik
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

Review 8.  Interferon induction and action.

Authors:  C Colby; M J Morgan
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

9.  Antiviral agent from lambda-infected Escherichia coli K-12. I. Isolation.

Authors:  Y M Centifanto
Journal:  Appl Microbiol       Date:  1968-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.